DE602005023468D1 - Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen - Google Patents

Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen

Info

Publication number
DE602005023468D1
DE602005023468D1 DE602005023468T DE602005023468T DE602005023468D1 DE 602005023468 D1 DE602005023468 D1 DE 602005023468D1 DE 602005023468 T DE602005023468 T DE 602005023468T DE 602005023468 T DE602005023468 T DE 602005023468T DE 602005023468 D1 DE602005023468 D1 DE 602005023468D1
Authority
DE
Germany
Prior art keywords
fibroblastes
dental
treatment
vascular cells
cryoplasty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005023468T
Other languages
English (en)
Inventor
Antoine Lafont
Bruno Gogly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Universite Paris 5 Rene Descartes
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Universite Paris 5 Rene Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Universite Paris 5 Rene Descartes filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of DE602005023468D1 publication Critical patent/DE602005023468D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE602005023468T 2004-07-02 2005-07-01 Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen Active DE602005023468D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0407357A FR2872431B1 (fr) 2004-07-02 2004-07-02 Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
PCT/FR2005/001690 WO2006013261A2 (fr) 2004-07-02 2005-07-01 Utilisation de fibroblastes gingivaux en therapie cellulaire vasculaire.

Publications (1)

Publication Number Publication Date
DE602005023468D1 true DE602005023468D1 (de) 2010-10-21

Family

ID=34946541

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005023468T Active DE602005023468D1 (de) 2004-07-02 2005-07-01 Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen

Country Status (11)

Country Link
US (2) US8119122B2 (de)
EP (1) EP1773420B1 (de)
JP (1) JP4891903B2 (de)
AT (1) ATE480265T1 (de)
AU (1) AU2005268746B2 (de)
CA (1) CA2572554C (de)
DE (1) DE602005023468D1 (de)
DK (1) DK1773420T3 (de)
ES (1) ES2354220T3 (de)
FR (1) FR2872431B1 (de)
WO (1) WO2006013261A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500335A (ja) 2006-08-10 2010-01-07 ユニベルシテ ルネ デカルト−パリ サンク 皮膚創傷を治療する方法
US7951593B2 (en) * 2007-03-20 2011-05-31 Universite Rene Descartes-Paris V Culture medium for gingival fibroblasts
JP5476515B2 (ja) * 2007-10-09 2014-04-23 ユニヴェルシテ・パリ・デカルト 細胞を投与するデバイス
DK2257272T3 (da) * 2008-03-31 2014-01-20 Scarcell Therapeutics Fremgangsmåde til kosmetisk behandling af fotoaldring i hud
JP5839467B2 (ja) * 2009-03-06 2016-01-06 ユニベルシテ パリ デカルト 癌を治療するための方法
WO2011012575A1 (en) 2009-07-27 2011-02-03 Scarcell Therapeutics Balloon catheter device
FR3008316B1 (fr) * 2013-07-09 2020-01-31 Assistance Publique - Hopitaux De Paris Utilisation de fibroblastes gingivaux dans le traitement de l'alopecie
US11179420B2 (en) * 2016-04-27 2021-11-23 Rohto Pharmaceutical Co., Ltd. Method for treating a disease, comprising administering mesenchymal stem cells or culture supernatant thereof to a subject
EP3541399A1 (de) * 2016-11-18 2019-09-25 Scarcell Therapeutics Zusammensetzungen zur verwendung bei der behandlung von immunerkrankungen
TW202038976A (zh) * 2018-11-30 2020-11-01 日商資生堂股份有限公司 用以治療或預防皮膚之色素沉著之組合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2678945B2 (ja) * 1989-04-17 1997-11-19 有限会社ナイセム 人工血管とその製造方法及び人工血管用基質
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
WO1997045533A1 (en) * 1996-05-28 1997-12-04 The Regents Of The University Of Michigan Engineering oral tissues
WO1999051164A1 (en) * 1998-04-03 1999-10-14 Reprogenesis, Inc. Soft tissue reconstructor and method of use
WO2001082773A2 (en) * 2000-04-28 2001-11-08 The Regents Of The University Of California Structures useful for bone engineering and methods
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells

Also Published As

Publication number Publication date
CA2572554A1 (fr) 2006-02-09
JP4891903B2 (ja) 2012-03-07
WO2006013261A2 (fr) 2006-02-09
EP1773420B1 (de) 2010-09-08
US8119122B2 (en) 2012-02-21
US8609085B2 (en) 2013-12-17
US20080025954A1 (en) 2008-01-31
ES2354220T3 (es) 2011-03-11
FR2872431A1 (fr) 2006-01-06
AU2005268746B2 (en) 2011-01-06
CA2572554C (fr) 2013-09-10
WO2006013261A3 (fr) 2006-06-15
DK1773420T3 (da) 2011-01-10
EP1773420A2 (de) 2007-04-18
ATE480265T1 (de) 2010-09-15
FR2872431B1 (fr) 2007-07-20
AU2005268746A1 (en) 2006-02-09
JP2008505164A (ja) 2008-02-21
US20120177613A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
DE602005023468D1 (de) Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE439863T1 (de) Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie
DE602004012816D1 (de) Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen
ATE554725T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
ATE530142T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
DE112005001005A5 (de) Biokompatible Beschichtung, Verfahren und Verwendung von medizinischen Oberflächen
DE602006018354D1 (de) Verfahren zur behandlung von abnormalem zellwachstum
DE602006014949D1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
ATE523196T1 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602004024909D1 (de) Platinkomplexe zur behandlung von tumoren
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
DE60335608D1 (de) Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
ATE555380T1 (de) Verfahren zur änderung des schicksals von zellen
ATE438404T1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
DE602005019247D1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
DE102005001078A8 (de) Glaspulver, insbesondere biologisch aktives Glaspulver und Verfahren zur Herstellung von Glaspulver, insbesondere biologisch aktivem Glaspulver
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut